BMEA
Price
$1.09
Change
-$0.08 (-6.78%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
77.77M
137 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$4.17
Change
-$0.12 (-2.80%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
231.57M
110 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMEA vs VYGR

Header iconBMEA vs VYGR Comparison
Open Charts BMEA vs VYGRBanner chart's image
Biomea Fusion
Price$1.09
Change-$0.08 (-6.78%)
Volume$17.96K
Capitalization77.77M
Voyager Therapeutics
Price$4.17
Change-$0.12 (-2.80%)
Volume$6.84K
Capitalization231.57M
BMEA vs VYGR Comparison Chart in %
BMEA
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BMEA vs. VYGR commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (BMEA: $1.17 vs. VYGR: $4.28)
Brand notoriety: BMEA and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 44% vs. VYGR: 69%
Market capitalization -- BMEA: $77.77M vs. VYGR: $231.57M
BMEA [@Biotechnology] is valued at $77.77M. VYGR’s [@Biotechnology] market capitalization is $231.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than BMEA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 5 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • BMEA’s TA Score: 5 bullish, 4 bearish.
  • VYGR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BMEA is a better buy in the short-term than VYGR.

Price Growth

BMEA (@Biotechnology) experienced а -16.43% price change this week, while VYGR (@Biotechnology) price change was +0.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

BMEA is expected to report earnings on Apr 06, 2026.

VYGR is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($232M) has a higher market cap than BMEA($77.8M). VYGR YTD gains are higher at: -26.543 vs. BMEA (-71.649). BMEA has higher annual earnings (EBITDA): -113.26M vs. VYGR (-119.18M). BMEA has more cash in the bank: 56.2M vs. VYGR (43.9M). BMEA has less debt than VYGR: BMEA (7.05M) vs VYGR (40.2M). VYGR has higher revenues than BMEA: VYGR (42.6M) vs BMEA (0).
BMEAVYGRBMEA / VYGR
Capitalization77.8M232M34%
EBITDA-113.26M-119.18M95%
Gain YTD-71.649-26.543270%
P/E RatioN/A6.00-
Revenue042.6M-
Total Cash56.2M43.9M128%
Total Debt7.05M40.2M18%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMEAVYGR
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
BMEA
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OERLF3.600.23
+6.82%
OC Oerlikon Corp.
HLBZF239.816.65
+2.85%
HEIDELBERG MATERIALS AG
KCKSF0.28N/A
N/A
Keck Seng Investments
TMNSF85.63N/A
N/A
Temenos AG
NFTM0.04N/A
-10.91%
The NFT Marketplace Inc.

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with CAI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then CAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
-6.78%
CAI - BMEA
38%
Loosely correlated
+0.51%
CCCC - BMEA
36%
Loosely correlated
+0.60%
MLTX - BMEA
36%
Loosely correlated
+1.12%
VYGR - BMEA
36%
Loosely correlated
-2.69%
SYRE - BMEA
35%
Loosely correlated
+0.83%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-2.69%
RGNX - VYGR
54%
Loosely correlated
-2.84%
KYMR - VYGR
54%
Loosely correlated
+0.95%
IMTX - VYGR
53%
Loosely correlated
N/A
BDTX - VYGR
49%
Loosely correlated
-2.02%
XNCR - VYGR
49%
Loosely correlated
-1.62%
More